Dual-surface modification of the tobacco mosaic virus

Journal of the American Chemical Society

Volumn 127, Issue 11, 2005, Pages 3718-3723

  Schlick, Tara L ^a   Ding, Zhebo ^a   Kovacs, Ernest W ^a   Francis, Matthew B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; CHROMOPHORES; ETHERS; NANOSTRUCTURED MATERIALS; ORGANIC ACIDS; PROTEINS; SUBSTRATES; VIRUSES;

CAPSID ASSEMBLIES; COUPLING REACTIONS; TOBACCO MOSAIC VIRUS (TMV);

TOBACCO;

AMINE; BIOTIN; CROWN ETHER; CYANAMIDE; DIAZONIUM COMPOUND; GLUTAMIC ACID; MACROGOL; OXIME; VIRUS PROTEIN;

ARTICLE; CONJUGATION; PROTEIN MODIFICATION; REACTION ANALYSIS; TOBACCO MOSAIC VIRUS; VIRUS CAPSID;

CAPSID; GLUTAMIC ACID; MODELS, MOLECULAR; TOBACCO MOSAIC VIRUS; TYROSINE;

AMINES; CHROMOPHORES; ETHERS; ORGANIC ACIDS; PROTEINS; SUBSTRATES; TOBACCO; VIRUSES;

EID: 15744396333     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja046239n     Document Type: Article

References (33)

1. For lead references, see (a) Douglas, T.; Young, M. Nature 1998, 393, 152.
2. (b) Douglas, T.; Young, M. Adv. Mater. 1999, 11, 679.
3. (c) Douglas, T.; Strahle, E.; Willits, D.; Aitouchen, A.; Libera, M.; Young, M. Adv. Mater. 2002, 14, 415.
4. (d) Whaley, S. R.; English, D. S.; Hu, E. L.; Barbara, P. F.; Belcher, A. M. Nature 2000, 405, 665.
5. (e) Lee, S.-W.; Mao, C.; Flynn, C. E.; Belcher, A. M. Science 2002, 296, 892.
6. (f) Wang, Q.; Lin, T.; Tang, L.; Johnson, J. E.; Finn, M. G. Angew. Chem., Int. Ed. 2002, 41, 459.
7. (a) Wang, Q.; Kaltgrad, E.; Lin, T.; Johnson, J. E.; Finn, M. G. Chem. Biol. 2002, 9, 805.
8. (b) Wang, Q.; Chan, T. R.; Hilgraf, R.; Fokin, V. V.; Sharpless, K. B.; Finn, M. G. J. Am. Chem. Soc. 2003, 125, 3192-3193.
9. (c) Raja, K. S.; Wang, Q.; Gonzalez, M. J.; Manchester, M.; Johnson, J. E.; Finn, M. G. Biomacromolecules 2003, 4, 472.
10. (d) Smith, J. C.; Lee, K. B.; Wang, Q.; Finn, M. G.; Johnson, J. E.; Mrksich, M.; Mirkin, C. A. Nano Lett. 2003, 3, 883.
11. (a) Hooker, J. M.; Kovacs, E. W.; Francis, M. B. J. Am. Chem. Soc. 2004, 126, 3718.
12. (b) Meunier, S.; Strable, E.; Finn, M. G. Chem. Biol. 2004, 11, 319.
13. (c) For the interior modification of a heat-shock protein assembly, see: Flenniken, M. L.; Willits, D. A.; Brumfield, S.; Young, M. J.; Douglas, T. Nano Lett. 2003, 3, 1573.
14. For a general review of TMV structure and self-assembly, see: Klug, A. Philos. Trans. R. Soc. London B 1999, 354, 531.
15. Crystal structures from: (a) Bhyravbhatla, B.; Watowich, S. J.; Caspar, D. L. D. Biophys. J. 1998, 74, 604.
16. (b) Pattanayek, R.; Stubbs, G. J. Mol. Biol. 1992, 228, 516.
17. (a) Shenton, W.; Douglas, T.; Young, M.; Stubbs, G.; Mann, S. Adv. Mater. 1999, 11, 253.
18. (b) Dujardin, E.; Peet, C.; Stubbs, G.; Culver, J. N.; Mann, S. Nano Lett. 2003, 3, 413.
19. (c) Knez, M.; Bittner, A. M.; Boes, F.; Wege, C.; Jeske, H.; Maiss, E.; Kern, K. Nano Lett. 2003, 3, 1079.
20. (d) Knez, M.; Sumser, M.; Bittner, A. M.; Wege, C.; Jeske, H.; Martin, P.; Kern, K. Adv. Funct. Mater. 2004, 14, 116-124.
21. See also: (e) Mao, C. B.; Flynn, C. E.; Hayhurst, A.; Sweeney, R.; Qi, J. F.; Georgiou, G.; Iverson, B.; Belcher, A. M. P. Natl. Acad. Sci. U.S.A. 2003, 100, 6946.
22. The modification of recombinant TMV mutants bearing additional lysine residues has been reported: Demir M.; Stowell, M. H. B. Nanotechnology 2002, 13, 541.
23. Chapman, S. Methods in Molecular Biology, Vol 81: Plant Virology Protocols: From Virus Isolation to Transgenic Resistance; Humana Press: Totowa, NJ; pp 123-129.
24. The azo linkage could also be detected as a broad absorption in the UV-vis spectrum with a maximum at 330 nm. Upon comparison with model compounds prepared with p-cresol, the amount of azo absorption (relative to that of the TMV capsid) was approximately what would be expected for the reported level of conversion. However, this peak was not sufficiently resolved from the protein spectrum to allow quantitative measurement of the conversion by this method.
25. See Supporting Information for spectra.
26. For additional examples of PEG attachment to viral capsids, see: (a) O'Riordan, C. R.; LaChapelle, A.; DelGrado, C.; Parkes, V.; Wadsworth, S. C.; Smith, A, E.; Francis, G. E. Human Gene Therapy 1999, 10, 1349.
27. (b) Wang, Q.; Raja, K. S.; Janda, K. D.; Lin, T.; Finn, M, G. Bioconj, Chem. 2003, 14, 38. Also see ref 2c.
28. In the case of rhodamine derivative 7g, UV-vis absorption spectra agreed with the modification ratios reported in the table. Nonetheless, we consider the ESI-MS based ratios to be more accurate. See Supporting Information for details.
29. (a) Fraenkel-Conrat. H. Virology 1957, 4, 1.
30. (b) Scheele, R. B.; Lauffer, M. A. Biochemists 1967, 6, 3076.
31. (c) Durham, A. C. H.; Finch, J. T.; Klug, A. Nature New Biol. 1971, 229, 37.
32. Nguyen, T.; Francis, M. B. Org. Lett. 2003, 5, 3245.
33. Laemmli, U. K. Nature 1970, 227, 680.